OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Elizabeth Thomas

1 Projects | 1 Researchers | $175,000 Invested

2022

University of California, Irvine

Elizabeth Thomas

Salivary neurofilament light and YKL-40 as prognostic biomarkers of cognitive decline.

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Neuronal Degeneration
  • Status: Closed